- Home
- PSIX vs JANX Comparison
PSIX vs JANX Comparison
Compare PSIX & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSIX
- JANX
- Stock Information
- Founded
- PSIX 1985
- JANX 2017
- Country
- PSIX United States
- JANX United States
- Employees
- PSIX N/A
- JANX N/A
- Industry
- PSIX Industrial Machinery/Components
- JANX Biotechnology: Pharmaceutical Preparations
- Sector
- PSIX Industrials
- JANX Health Care
- Exchange
- PSIX Nasdaq
- JANX Nasdaq
- Market Cap
- PSIX 1.1B
- JANX 1.4B
- IPO Year
- PSIX N/A
- JANX 2021
- Fundamental
- Price
- PSIX $64.82
- JANX $22.92
- Analyst Decision
- PSIX Strong Buy
- JANX Strong Buy
- Analyst Count
- PSIX 1
- JANX 7
- Target Price
- PSIX $37.00
- JANX $94.29
- AVG Volume (30 Days)
- PSIX 441.5K
- JANX 664.1K
- Earning Date
- PSIX 08-08-2025
- JANX 08-06-2025
- Dividend Yield
- PSIX N/A
- JANX N/A
- EPS Growth
- PSIX 172.88
- JANX N/A
- EPS
- PSIX 3.53
- JANX N/A
- Revenue
- PSIX $516,173,000.00
- JANX $9,336,000.00
- Revenue This Year
- PSIX $12.55
- JANX N/A
- Revenue Next Year
- PSIX $8.36
- JANX $1,470.82
- P/E Ratio
- PSIX $18.32
- JANX N/A
- Revenue Growth
- PSIX 17.92
- JANX 28.12
- 52 Week Low
- PSIX $6.33
- JANX $22.48
- 52 Week High
- PSIX $69.34
- JANX $71.71
- Technical
- Relative Strength Index (RSI)
- PSIX N/A
- JANX 40.54
- Support Level
- PSIX N/A
- JANX $22.56
- Resistance Level
- PSIX N/A
- JANX $24.19
- Average True Range (ATR)
- PSIX 0.00
- JANX 1.33
- MACD
- PSIX 0.00
- JANX -0.05
- Stochastic Oscillator
- PSIX 0.00
- JANX 12.55
About PSIX Power Solutions International Inc. Common Stock
Power Solutions International Inc is an America-based company that manufactures, distributes, and services power systems that run on nondiesel fuels, including natural gas, propane, and gasoline. The company's products are designed to meet emission standards imposed by environmental regulatory bodies like the Environmental Protection Agency. Its products are distributed to a wide range of industrial original equipment manufacturers that supply equipment to sectors including power generation, oil and gas, material handling, airport ground support, agricultural, turf, construction and irrigation. The company generates majority of its sales from United States.
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.